Clopidogrel + aspirin in atrial fibrillation

Kuritzky, Louis
August 2009
Primary Care Reports;Aug2009 Supplement, p15
The article discusses research on the impact of clopidogrel and aspirin in patients suffering from atrial fibrillation (FIB). It references the study "The ACTIVE Investigators: Effect of Clopidogrel Added to Aspirin in Patients With Atrial Fibrillation" published in a 2009 issue of the "New England Journal of Medicine." The study found that risk of major bleeding is raised by 57 percent.


Related Articles

  • The P450 system and CV outcomes with clopidogrel. Kuritzky, Louis // Internal Medicine Alert;12/15/2010 Supplement, p183 

    The article offers information on the impact of the P450 system and clopidogrel on the reduction of cardio-vascular events (CV) among people with atrial fibrillation.

  • Vascular risk factors don't impact safety of apixaban.  // Reactions Weekly;10/13/2012, Issue 1423, p4 

    The article focuses on a study which compared the benefits of apixaban with warfarin in patients with atrial fibrillation.

  • Study: Aspirin had no effect on stroke, thromboembolism risk in AF patients. Murphy, Casey // Cardiology Today;Nov2011, Vol. 14 Issue 11, p1 

    The article focuses on a study which found that aspirin has no effect on stroke and thromboembolism risk in patients with atrial fibrillation (AF).

  • The P450 system and CV outcomes with clopidogrel.  // Primary Care Reports;Jan2011 Clinical Briefs in Primary, Vol. 16 Issue 1, p1 

    The article discusses a research study conducted on subjects with atrial fibrillation or post-acute coronary syndrome (ACS) who were exposed to clopidogrel and received CYP2C19, concluding that the P450 system and clopidogrel do not ensure positive effects on cardiovascular outcomes or bleeding...

  • Effect of clopidogrel added to aspirin in patients with atrial fibrillation.  // Australian Journal of Pharmacy;Oct2009, Vol. 90 Issue 1073, p68 

    The article discusses the effects of clopidogrel when added to aspirin which are given to patients with atrial fibrillation. It notes that a study was made to investigate the hypothesis that adding clopidogrel to aspirin will reduce the risk of vascular events in patients with atrial...

  • Genotypes linked with antiplatelet effect of clopidogrel.  // Cardiology Today;Nov2010, Vol. 13 Issue 11, p11 

    This article focuses on a study which examined the relative effects of demographic and clinical variables versus the presence of CYPC19*2 polymorphism on the antiplatelet effects of clopidogrel.

  • Challenges with clopidogrel pave potential road for new agents.  // Cardiology Today;Nov2010, Vol. 13 Issue 11, p12 

    The article discusses studies which examined the effects of dual antiplatelet therapy such as clopidogrel and the interactions between clopidogrel and proton pump inhibitors.

  • Cancer: Preserving fertility during chemotherapy. Charlotte, Harrison // Nature Reviews Drug Discovery;Jul2013, Vol. 12 Issue 7, p506 

    The article discusses research being done on the effect of anticancer drug cyclophosphamide on fertility, referencing a study by L. Kalich-Philosoph et al published in a 2013 issue of "Science Translational Medicine."

  • Aspirin for primary prevention of CV events. Kuritzky, Louis // Primary Care Reports;Aug2009 Supplement, p16 

    The article discusses research on aspirin against cardiovascular (CV) events. It references the study "Antithrombotic Trialists Collaboration: Aspirin in the Primary and Secondary Prevention of Vascular Disease," published in a 2009 issue of the journal "Lancet." According to the study, intake...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics